by The global custom antibody market size is expected to increase USD 444.66 million by 2033 from USD 175.70 million in 2023 with a CAGR of 9.73% between 2024 and 2033.
Key Points
- The North America custom antibody market size reached USD 80.82 million in 2023 and is expected to attain around USD 206.77 million by 2033, poised to grow at a CAGR of 9.84% between 2024 and 2033.
- North America dominated the market with the largest revenue share of 46% in 2023.
- Asia Pacific is estimated to be the fastest-growing during the forecast period of 2024-2033.
- By type, the monoclonal antibodies segment has contributed more than 51% of revenue share in 2023.
- By type, the recombinant antibodies segment is expected to grow at a soldi CAGR of 11.93% during the forecast period.
- By service, the antibody development segment has held a major revenue share of 55% in 2023.
- By source, the rabbit segment has recorded more than 50% of revenue share in 2023.
- By source, the mice segment is estimated to be the fastest-growing during the forecast period.
- By application, the infectious disease segment has generated more than 28% of revenue share in 2023.
- By application, the oncology segment is the fastest-growing during the forecast period.
- By end-use, the academic research & institutes segment dominated has captured the biggest revenue share of 58% in 2023.
- By end-use, the pharmaceutical & biotechnology companies segment is the fastest-growing during the forecast period.
The custom antibody market involves the production of antibodies tailored for specific applications, including research, diagnostics, and therapeutic uses. These antibodies are designed to target specific antigens, offering high specificity and affinity. The market caters to various industries such as biotechnology, pharmaceutical, and academic research institutions. Custom antibodies play a crucial role in advanced research areas, including cancer, immunology, and infectious diseases.
Get a Sample: https://www.precedenceresearch.com/sample/4562
Growth Factors
Key factors driving the growth of the custom antibody market include the increasing demand for personalized medicine, advancements in antibody production technologies, and the rising prevalence of chronic diseases. The growing focus on research and development in life sciences and biotechnology sectors also significantly contributes to market expansion. Additionally, the ability of custom antibodies to provide more precise and reliable results compared to traditional antibodies boosts their adoption.
Region Insights
North America holds a dominant position in the custom antibody market, attributed to the presence of major biotechnology and pharmaceutical companies, well-established research infrastructure, and substantial funding for life sciences research. Europe follows closely, with significant contributions from countries like Germany, the UK, and France. The Asia-Pacific region is expected to witness the fastest growth due to increasing investments in biotechnology, expanding pharmaceutical industries, and rising healthcare expenditures in countries like China and India.
Custom Antibody Market Scope
| Report Coverage | Details |
| Market Size by 2033 | USD 444.66 Million |
| Market Size in 2023 | USD 175.70 Million |
| Market Size in 2024 | USD 192.80 Million |
| Market Growth Rate from 2024 to 2033 | CAGR of 9.73% |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Type, Service, Source, Application, End-use, and Regions |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Custom Antibody Market Companies
- GenScript
- LifeSpan BioSciences, Inc
- Labcorp Drug Development
- Abmart
- YenZym Antibodies, LLC.
- Kaneka Eurogentec S.A.
- Bio-Rad Laboratories, Inc
- Abcam plc
- Creative Diagnostics
- Thermo Fisher Scientific Inc.
Recent Developments
- In October 2022, Absolute Biotech Company launched to offer antibody reagents, services, and expertise to researchers worldwide for therapeutic, diagnostic, and research applications. The company offers recombinant antibody expression, antibody engineering, custom antibody sequencing services, and more than one million off-the-shelf life science reagents.
- In March 2024, a leading biotechnology company in genetic medicine, Agathos Biologics, launched its rAAV (recombinant adeno-associated virus) production service by using the company’s new AE1-BHK cell line. The company recorded its first sale of rAAV to a CRO/CMO (contract research and manufacturing organization), Genovac, that discovers, manufactures, and develops antibodies for research, therapeutics, and diagnostics market segments.
Read Also: Benzenoid Market Size to Worth USD 1,417.40 Million by 2033
Custom Antibody Market Dynamics
Drivers
The primary drivers of the custom antibody market include the increasing focus on personalized medicine and targeted therapies, advancements in genetic and protein research, and the growing need for specific antibodies in various diagnostic and therapeutic applications. The continuous development of novel technologies for antibody production and the expanding use of custom antibodies in drug discovery and development further propel market growth.
Opportunities
The custom antibody market presents numerous opportunities, such as the growing interest in monoclonal and polyclonal antibodies for therapeutic use, the expanding application of custom antibodies in emerging fields like neurobiology and stem cell research, and the potential for developing antibodies against new and challenging targets. Collaborations between academic institutions and industry players also offer opportunities for innovation and market expansion.
Challenges
Despite the promising growth, the custom antibody market faces challenges such as high costs associated with antibody development and production, stringent regulatory requirements, and the technical complexities involved in producing high-quality, specific antibodies. Additionally, the need for skilled professionals and the time-consuming nature of custom antibody development can hinder market growth.
Segments Covered in the Report
By Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Others
By Service
- Antibody Development
- Antibody Production & Purification
- Antibody Fragmentation & Labeling
By Source
- Mice
- Rabbit
- Others
By Application
- Oncology
- Infectious Diseases
- Neurology
- Stem Cells
- Immunology
- Cardiovascular Diseases
- Others
By End-use
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- CRO
- Hospitals and Clinics
By Geography
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East & Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
